Aperio Group, LLC - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 87 filers reported holding GALENA BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2015$22,000
+4.8%
13,671
+35.0%
0.00%
Q3 2014$21,000
-38.2%
10,125
-10.0%
0.00%
Q2 2014$34,000
+17.2%
11,244
-3.9%
0.00%
Q1 2014$29,000
-50.0%
11,7010.0%0.00%
-100.0%
Q4 2013$58,00011,7010.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders